Gregg et al. demonstrate small but significant remission rates for type 2 diabetes mellitus (T2DM), achieved through an intensive lifestyle tertiary prevention trial. This finding reinforces existing evidence from intensive secondary prevention trials. But can these programmes be translated into the community with similar effects, or is primary prevention required to reduce the epidemic of T2DM?
- Adrian Bauman
- Alexis St George
